Publication Beamlines Strategic Pillar
Hedda WARDEMANN; Rajagopal MURUGAN; Tizian DECKER; Elena Levashina; Guilia COSTA et al. (2021). Plasmodium antibodies. Patent Number: WO2021001351A1.
Guo Shuaiqi; Voets Ilja; Davies Peter; Klose Karl (2021). Peptides for use in the treatment of cholera. Patent Number: NL2023527B1.
Folgueira Judit Anido; Teixidor Ester Bonfill; Johan Fransson; Garcia Monica Pascual; Rigol Ester Planas et al. (2021). COMBINATION OF LIF INHIBITORS AND PD-1 AXIS INHIBITORS FOR USE IN THE TREATMENT OF CANCER. Patent Number: MA52231A.
Edward Sargent; Phil DE LUNA; Fanglin CHE; Yansong ZHOU (2021). Boron-doped copper catalysts for efficient conversion of co2 to multi-carbon hydrocarbons and associated methods. Patent Number: EP3784819A1.
Edward Sargent; Cao-Thang DINH; Francisco PELAYO GARCIA DE ARQUER; Alexander IP (2021). Composite multilayered electrocatalysts for co2 reduction and associated methods. Patent Number: EP3571331B1.
Dorothea KOMINOS; Jie Zhang; Alla Pritsker; Matthew Davison; Nicolas Baurin et al. (2021). Antibodies to bradykinin b1 receptor ligands. Patent Number: MY184037A.
Attar Ricardo; D Powers Gordon; Gaudet Francois; Pillarisetti Kodandaram; Thomas Baldwin Eric et al. (2021). BCMA Antibodies, BCMA and CD3 Bispecific Antigen-Binding Molecules, and Their Uses. Patent Number: JO3799B1.
Andreas Ernst; Sachdev Sidhu; Linda Beatty (2021). Specific active site inhibitors of enzymes or substrate binding partners and methods of producing same. Patent Number: CA3053192C.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 피터 에드워드 베일리스; 아지타 제가나탄 et al. (2021). Methods for improving response to anti-LIF antibody treatment in a subject with cancer. Patent Number: KR20210024007A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A.
호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.
(2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A.
Ting, Michelle (2021). Impact of Transition Metal Redox on Next-Generation Li-Rich Cathodes for Li-Ion Batteries. McGill University. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwim36P8-puEAxWLjYkEHTo1DzEQFnoECBIQAQ&url=https%3A%2F%2Fescholarship.mcgill.ca%2Fdownloads%2F5h73q185g&usg=AOvVaw1lIj-8aN7hwOs5ybqe6OMI&opi=89978449. CLS-APS Materials
Thomas, Evan (2021). Designing and commissioning of a prototype high energy resolution fluorescence detection system at the Canadian Light Source. Supervisor: Jiang, De-Tong. Ontario, Canada: University of Guelph. https://hdl.handle.net/10214/23713. CLS-APS, HXMA Materials